首页 | 本学科首页   官方微博 | 高级检索  
     

辅助化疗在早期可手术非小细胞肺癌治疗中的地位
引用本文:闫相涛,朱辉,王慧娟,王启鸣,李鹏,马智勇. 辅助化疗在早期可手术非小细胞肺癌治疗中的地位[J]. 中国肺癌杂志, 2011, 14(3): 281-285. DOI: 10.3779/j.issn.1009-3419.2011.03.15
作者姓名:闫相涛  朱辉  王慧娟  王启鸣  李鹏  马智勇
作者单位:河南省肿瘤医院肿瘤内科,郑州,450000
摘    要:肺癌患者术后复发转移是临床治疗失败的主要原因,因此亟待一种更系统的治疗手段来完善患者的治疗计划,以降低复发率、延长生存期。辅助化疗(包括新辅助化疗、术后辅助化疗、靶向药物辅助化疗)应运而生。本文就辅助治疗领域的研究进展进行综述。

关 键 词:肺肿瘤  辅助化疗  靶向治疗

The Role of Adjuvant Chemotherapy in Operable Non-small Cell Lung Cancer
Xiangtao YAN,Hui ZHU,Huijuan WANG,Aiming WANG,Peng LI,Zhiyong MA. The Role of Adjuvant Chemotherapy in Operable Non-small Cell Lung Cancer[J]. Chinese journal of lung cancer, 2011, 14(3): 281-285. DOI: 10.3779/j.issn.1009-3419.2011.03.15
Authors:Xiangtao YAN  Hui ZHU  Huijuan WANG  Aiming WANG  Peng LI  Zhiyong MA
Affiliation:Xiangtao YAN,Hui ZHU,Huijuan WANG,Qiming WANG,Peng LI,Zhiyong MA Depatment of Medical Oncology,Henan Tumor Hosipital,Zhengzhou 450000,China
Abstract:Postoperative recurrence is the main cause of primary treatment failure in the resectable non-small cell lung cancer(NSCLC) .Systematic treatments should be taken to decrease the recurrence.Adjuvant chemotherapy,including neoadjuvant chemotherapy,postoperative adjuvant chemotherapy and targeted therapy,is a widely used in this area.In this review,we summarize the clinical trials and meta-analysis related to the adjuvant chemotherapy and targeted therapy in patients with early stage NSCLC.
Keywords:Lung neoplasms  Adjuvant chemotherapy  Targeted therapy  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号